Helen of Troy (NASDAQ:HELE) Releases FY 2027 Earnings Guidance

Helen of Troy (NASDAQ:HELEGet Free Report) updated its FY 2027 earnings guidance on Wednesday morning. The company provided EPS guidance of 3.250-3.750 for the period, compared to the consensus EPS estimate of 3.380. The company issued revenue guidance of $1.8 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion.

Helen of Troy Stock Performance

NASDAQ:HELE opened at $28.04 on Wednesday. The company’s 50-day moving average is $26.12 and its two-hundred day moving average is $20.82. Helen of Troy has a 1-year low of $13.85 and a 1-year high of $31.98. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.71 and a quick ratio of 0.81. The firm has a market capitalization of $653.05 million, a price-to-earnings ratio of -0.72 and a beta of 1.31.

Helen of Troy (NASDAQ:HELEGet Free Report) last released its quarterly earnings results on Wednesday, July 8th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.15. The business had revenue of $402.12 million during the quarter, compared to analysts’ expectations of $374.55 million. Helen of Troy had a positive return on equity of 7.00% and a negative net margin of 50.33%.Helen of Troy has set its FY 2027 guidance at 3.250-3.750 EPS. Analysts forecast that Helen of Troy will post 2.81 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on HELE. Canaccord Genuity Group increased their price target on Helen of Troy from $18.00 to $23.00 and gave the company a “hold” rating in a research report on Friday, April 24th. Wall Street Zen downgraded Helen of Troy from a “buy” rating to a “hold” rating in a report on Saturday, May 23rd. UBS Group increased their price target on shares of Helen of Troy from $16.00 to $25.00 and gave the stock a “neutral” rating in a research note on Friday, April 24th. Weiss Ratings restated a “sell (d-)” rating on shares of Helen of Troy in a research note on Wednesday, June 24th. Finally, Zacks Research downgraded shares of Helen of Troy from a “strong-buy” rating to a “hold” rating in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Helen of Troy has a consensus rating of “Hold” and a consensus target price of $24.00.

Check Out Our Latest Report on Helen of Troy

Key Stories Impacting Helen of Troy

Here are the key news stories impacting Helen of Troy this week:

  • Positive Sentiment: Helen of Troy reported first-quarter fiscal 2027 revenue of $402.1 million, above last year’s $371.7 million, and stronger profitability than the prior-year period. The company also said earnings beat expectations, which supports the stock. Helen of Troy Reports First Quarter Fiscal 2027 Results
  • Positive Sentiment: The company raised FY2027 guidance, with EPS forecast at $3.25 to $3.75, and investors are reacting to the fact that the outlook remains solid even after a challenging prior year. Helen of Troy Reports First Quarter Fiscal 2027 Results
  • Neutral Sentiment: Zacks Research downgraded Helen of Troy from “strong-buy” to “hold,” which may temper enthusiasm but does not signal a major selloff on its own. Zacks downgrade coverage
  • Negative Sentiment: Multiple law firms issued investor alerts about a class-action lawsuit against Helen of Troy, keeping legal overhang in focus and adding a potential risk for shares. Investor alert on class action lawsuit
  • Negative Sentiment: Analyst commentary from Canaccord Genuity kept a hold rating and left the price target at $23, suggesting limited near-term upside versus the current trading level. Hold rating maintained

Institutional Trading of Helen of Troy

Several institutional investors have recently added to or reduced their stakes in the stock. iSAM Funds UK Ltd acquired a new position in shares of Helen of Troy during the third quarter valued at about $27,000. Larson Financial Group LLC boosted its stake in shares of Helen of Troy by 1,323.2% in the 3rd quarter. Larson Financial Group LLC now owns 1,352 shares of the company’s stock valued at $34,000 after purchasing an additional 1,257 shares in the last quarter. Tower Research Capital LLC TRC lifted its position in Helen of Troy by 216.1% in the second quarter. Tower Research Capital LLC TRC now owns 1,998 shares of the company’s stock valued at $57,000 after purchasing an additional 1,366 shares during the last quarter. Lazard Asset Management LLC bought a new stake in shares of Helen of Troy during the 2nd quarter valued at $67,000. Finally, Empowered Funds LLC purchased a new position in shares of Helen of Troy in the fourth quarter valued at about $148,000.

Helen of Troy Company Profile

(Get Free Report)

Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.

The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.

Featured Articles

Earnings History and Estimates for Helen of Troy (NASDAQ:HELE)

Receive News & Ratings for Helen of Troy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helen of Troy and related companies with MarketBeat.com's FREE daily email newsletter.